Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

31 results about "Diastolic phase" patented technology

Diastole is divided into four phases and comprises 2/3 of the cardiac cycle. It begins when the aortic valve closes. This is the start of Isovolumic Relaxation (volume remains constant but the pressure in the ventricles fall). The next phase of diastole occurs when the mitral valve opens and allows for rapid ventricular filling.

Contactless System and Method For Measuring and Continuously Monitoring Arterial Blood Pressure

A contactless system for measuring and continuously monitoring arterial blood pressure includes a light source configured to illuminate light having at least one predetermined wavelength at a predetermined area of a human subject having an artery therein. A detector responsive to reflected light from the predetermined area is configured to continuously acquire images of the artery in the predetermined area. A processor is configured to process the images and determine: when an image at a proximal location of the predetermined area is darker indicating transition of a pulse wave into the artery at the proximal location and at a proximal time and when an image at a distal location of the predetermined area is darker indicating transition of the pulse wave into the artery at a distal location at a distal time, determine the difference in time between the distal time and the proximal time to calculate a pulse transit time (PTT), determine a length between the proximal location and the distal location, determine a diameter of the artery during a systolic phase of a cardiac pulse, determine a diameter of the artery during a diastolic phase of a cardiac pulse, calculate a pulse wave velocity of the pulse wave, calculate pulse pressure (ΔP), calculate an elastic modulus (E) of the artery, and contactlessly and continuously calculate the arterial blood pressure for each cardiac cycle of the human subject.
Owner:VIVONICS

Mr imaging with b1 mapping

The invention relates to a method of MR imaging, wherein a portion of a body (10) placed in the examination volume of a MR device (1) is subjected to an imaging sequence (IMG) of RF pulses and switched magnetic field gradients. The imaging sequence (IMG) is a stimulated echo sequence including i) at least two preparation RF pulses (α) radiated toward the portion of the body (10) during a preparation period (21), and ii) one or more reading RF pulses (β) radiated toward the portion of the body (10) during an acquisition period (22) temporally subsequent to the preparation period (21). One or more FID signals (I1) and one or more stimulated echo signals (I2) are acquired during the acquisition period (22). A B1 map indicating the spatial distribution of the RF field of the RF pulses within the portion of the body (10) is derived from the acquired FID (I1) and stimulated echo (I2) signals. It is an object of the invention to provide an improved B1 mapping method which can be applied in magnetic resonance angiography (MRA) and, in particular, in cardiac imaging, where the acquisition of a complete B1 map needs to be performed within the diastolic phase of the heartbeat. The invention proposes that the portion of the body (10) is subjected to a suppression sequence (BB) for suppression of MR signals emanating from blood prior to the imaging sequence (IMG). Moreover, the invention relates to a MR device (1) and to a computer program for a MR device (1).
Owner:KONINKLJIJKE PHILIPS NV

Ultrasonic equipment, ultrasonic image processing method and storage medium

The invention discloses ultrasonic equipment, an ultrasonic image processing method and a storage medium, which are used for automatically measuring heart state parameters and improving the measurement accuracy. The equipment comprises a processor and a display. The processor obtains an image sequence composed of ultrasonic images from the continuously collected ultrasonic image information of the heart; the ventricular volume corresponding to each frame of ultrasonic image in the image sequence is determined to obtain a ventricular volume sequence; the end-diastolic volume corresponding to the central ventricular end diastolic phase of at least one cardiac cycle and the end-systolic volume corresponding to the ventricular end-systolic phase is determined according to the change trend of the central ventricular volume of the ventricular volume sequence; and heart state parameters can be determined according to the end-diastolic volume and the end-systolic volume. The ventricular volume is determined according to the ultrasonic images in the acquired image sequence, so that the ventricular volume is determined quickly and accurately; the heart state parameters are determined according to the determined end-diastolic volume and end-systolic volume, so that the accuracy of the heart state parameters is improved.
Owner:QINGDAO HISENSE MEDICAL EQUIP

Ejecting fraction data processing method and device based on cardiac ultrasound video

The embodiment of the invention relates to an ejection fraction data processing method and device based on a cardiac ultrasound video. The method comprises the steps that the cardiac ultrasound video is acquired; performing image framing to obtain a first framed image sequence; performing left ventricle lengthwise axis key point identification on each first sub-frame image based on an image target key point identification model; performing left ventricle semantic segmentation processing on each first framing image based on an image semantic segmentation model to generate a second framing image with a left ventricle segmented sub-image; screening processing of framing images at the end of a systolic period and at the end of a diastolic period is carried out on the second framing image sequence; performing left ventricular volume calculation to generate corresponding left ventricular volume parameters; generating a systolic end volume mean value and a diastolic end volume mean value; and ejection fraction data is calculated and generated according to the volume mean value of the end of the systolic period and the end of the diastolic period. By means of the method, the manual intervention link in a traditional method can be eliminated, and the ejection fraction calculation precision and accuracy can be improved.
Owner:LEPU MEDICAL TECH (BEIJING) CO LTD

Minimally invasive path of extracorporeal blood pump aorta counterpulsation circulation auxiliary device and implantation method

ActiveCN110975113ARaise diastolic blood pressureReduce loadBalloon catheterEngineeringMechanical engineering
The invention relates to a minimally invasive path of an extracorporeal blood pump aorta counterpulsation circulation auxiliary device and an implantation method. The implantation method of the extracorporeal blood pump aorta counterpulsation minimally invasive path is characterized in that: making a cutting mark in the center of sternum corresponding to a selected part on an aortic valve, drilling a circular hole, implanting and fixing a counterpulsation pump pipeline into an ascending aorta through minimally invasive surgery, and connecting the pipeline to an external counterpulsation pump balloon after exhausting. The method has the advantages that: the circular hole is drilled in the center of the sternum, a hose is implanted into the ascending aorta and fixed through minimally invasive surgery, and the hose is connected to the external counterpulsation pump balloon after exhausting. Through pressure or electrocardio waveforms, a controller achieves synchronous counterpulsation assistance through the diastolic period of the counterpulsation pump, and the purposes of assisting circulation and treating heart failure are achieved. The cure rate of acute heart failure can be greatly improved; after implantation, physical strength permitted, the patient is allowed to take food, urinate, defecate and move out of bed by himself/herself; the ICU residence time is shortened; and long-time assistance is achieved, and no obvious complications exist.
Owner:张杰民
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products